慢性淋巴性白血病治療藥市場：單株抗體的效果

本報告已在2011年12月21日停止出版。

簡介

目錄

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Current research is focusing on the urgent unmet need for agents that improve survival. Improved responses from treatment regimens that combine targeted biological agents with established chemotherapy, as well as increased drug therapy for early-stage patients who are likely to progress based on potential prognostic markers, have already begun and will continue to create market opportunities and propel steady growth of the CLL market. In this report, we provide an overview of CLL, including its staging, epidemiology, and biological markers. We discuss the current treatments and promising late-stage agents in development for CLL, as well as the market outlook though 2010.

Table of Contents

• Introduction
• Leukemia
• Characteristics
• Etiology and Pathophysiology
• Symptoms
• Staging and Survival
• Epidemiology
• Prognosis
• Options for Chronic Lymphocytic Leukemia
• Treatment
• Decisions
• Line Therapies
• Second-Line Therapies
• Therapies
• Emerging Therapies for Chronic Lymphocytic
• Leukemia
• Antibodies
• Rituximab
• Lumiliximab
• Other Monoclonal Antibodies
• Immunotoxins
• Inhibitors
• Antisense Oligonucleotides
• Outlook
• Table 1 Common Staging Systems Used in the Treatment of CLL
• Table 2 Select Current Therapies Used for the Treatment of CLL, 2006
• Table 3 NCI Definition of Response to Treatment in CLL Patients
• Table 4 Select Emerging Therapies for the Treatment of CLL in the United States, 2006
• Figure 1 Treatment Algorithm for Chronic Lymphocytic Leukemia

相關商品

癌症相關市場調查報告書

乳癌、大腸癌、血管增生分析
Triple Analysis: Breast Cancer, Colorectal Cancer and Angiogenesis
價格 : US $ 5175
出版日期 : 2012年01月

大腸癌、淋巴癌、血管增生分析
Triple Analysis: Colorectal Cancer, Lymphoma and Angiogenesis
價格 : US $ 5175
出版日期 : 2012年01月

大腸癌、黑色素細胞癌、血管增生分析
Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis
價格 : US $ 5175
出版日期 : 2012年01月

Decision Resources, Inc.發行的製藥相關市場調查報告書

傳染病疫苗開發平台:競爭檢討

Special Report: The Infectious Disease Vaccine Pipeline--A Competitive Review

價格 : US $ 9200

出版日期 : 2011年06月

感染疾病疫苗:未滿足需求和對醫藥品產業來說的機會

Special Report: Infectious Disease Vaccines--Unmet Needs and Opportunities for Pharma

價格 : US $ 9200

出版日期 : 2011年06月

自閉症譜系障礙:高未滿足需求創造出很大的市場機會

Special Report: Autism Spectrum Disorders--High Unmet Needs Create Significant Market Opportunities

價格 : US $ 9200

出版日期 : 2011年06月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!